Skip to content

Author

Jawed Iqbal

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Clinical Trends and Postoperative Complications in Cataract Surgery: A Six-Months Study

Background: “ Cataract is the leading cause of reversible blindness worldwide, with surgery being the only definitive treatment. Despite advances, variations in surgical patterns and postoperative complications remain clinically significant. Aim: To evaluate the patterns of cataract surgery and associated postoperative complications over six months. Methodology: A prospective observational study was conducted at the Department of Ophthalmology, Anugrah Narayan Magadh Medical College, Gaya ji, Bihar, India, including 80 patients aged ≥40 years undergoing cataract surgery. Data on demographics, surgical techniques, intraoperative and postoperative complications, and visual outcomes were recorded. Surgeries included phacoemulsification, ECCE, and MSICS. Postoperative follow-up extended to six months, and statistical analysis was performed using SPSS v27. Results: Patients were predominantly elderly, with a slight female predominance (52.5%). Phacoemulsification was the most common procedure (52.5%), with posterior chamber foldable IOLs implanted in 66.3% of cases. Intraoperative complications occurred in 13.7%, with posterior capsule rupture being most frequent. Postoperative complications were infrequent, with corneal edema (10%) and posterior capsule opacification (7.5%) being the most common. Conclusion: Phacoemulsification with posterior chamber foldable IOLs provides excellent visual outcomes with low complication rates. Patient selection, surgical expertise, and structured postoperative follow-up are critical for” optimal outcomes

Sushmita Chaudhary, Priya Ranjan, Jawed Iqbal · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.